overweight_woman_new.jpg
 

The Safe Solution For Normalizing Blood Sugar Levels.

Sigrid Therapeutics® is pioneering a user-friendly product made of precisely engineered particles with extraordinary absorptive capacity. It works mechanically in the gut to improve glycemic control in a safe and effective way.  

 

Advancing Novel Solutions for Metabolic Health. 

 

The Sigrid Solution

Whereas current products on the market are riddled with side effects, Sigrid's solution is precisely engineered to lower lipid and HbA1c levels without compromising safety. Smartly designed, our solution are biocompatible micro-sized particles. These particles are precisely engineered from minerals, to contain nano-sized pores, which are Generally Recognized as Safe by the Food and Drug Administration. After oral consumption, Sigrid’s particles work mechanically in the gut by lowering energy intake through several gentle mechanisms. Unlike existing drugs which are taken up and circulated in the bloodstream, Sigrid’s product is user-friendly with no systemic uptake. The particles stay and function locally in the gut, and are eventually removed by the body’s natural excretion cycle. 

Research & Development

Sigrid’s therapeutic solution is the result of groundbreaking scientific research and intellectual property developed at the obesity and diabetes laboratory of Professor Tore Bengtsson at Stockholm University. Professor Bengtsson has over 20 years of experience in metabolism, obesity and its related diseases. Since its discovery in 2012, the Sigrid team has worked collaboratively with renowned global research institutes, including Karolinska Institute, KTH Royal Institute of Technology and Monash University in further developing and optimising our product. Combining expertise from different fields, including biochemistry, material sciences and clinical insights and practice, ensures continuous progress in our research and development.

Edited-1128.jpg

Our
Story

The Sigrid Story began in 2008, when our researchers started exploring the promise of engineered materials in biomedical applications within the field of obesity and its related diseases. After years of dedicated research and materials development, a significant discovery was made. In reference to the Old Norse origin, Sigrid was founded in 2014, representing the “beautiful victory”, accomplished through the team's efforts. We remain determined to transform our discovery into a meaningful product. Sigrid stands for optimal safety and well-being, striving to empower you to commit to a healthier life. 


Research Collaborations

 

 
Screen Shot 2015-03-16 at 10.18.48 am.png

Contact

 

universitetsvägen 8 (Villa bellona) 
SE-106 91 Stockholm
Sweden

Name *
Name

Management

Sana Alajmovic,
B.Sc.

Co-Founder & CEO

Professor Tore Bengtsson, 
Ph.D.

Co-Founder & CSO

Dr. Eric Johnston, 
Ph.D. 

CTO

Dr. Maria Lindgren,
Ph.D.

Head of Clinical Development

 

Board of Directors

Ulf Wiinberg

Working Chairman

Mats Arnhög,
Ph.D.

Deputy Board Member

Sana Alajmovic,
B.Sc.

Board Member

Professor Tore Bengtsson,
Ph.D.

Deputy Board Member

Giovanni Fili,
M.Sc.

Board Member

Dr. Roger G. Berlin, 
M.D.

Adjunct Board Member

Advisory Board

Professor Stephan Rössner, 
M.D., Ph.D.

Clinical Advisor

Professor Claude Marcus,
M.D., Ph.D.

Clinical Advisor

Professor Ben Boyd,
Ph.D.
Scientific Advisor

Dr. Arvo Hänni, 
M.D., Ph.D.

Clinical Advisor

Professor Adam Feiler,
Ph.D.

Scientific Advisor

Professor Mikael Rydén, 
M.D., Ph.D.
Clinical Advisor

Dr. Roger G. Berlin, 
M.D.

Scientific Advisor